Professional Seasonal Analysis for Trading

Collegium Pharmaceutical, Inc. - Common Stock (COLL)

Seasonality Analysis

Stocks 11 Years Analyzed

Collegium Pharmaceutical, Inc. - Common Stock Annual Seasonality Statistics

26.03%
Avg Annual Return
50.0%
Avg Monthly Win Rate
6/12
Positive Months
11
Years Analyzed

Collegium Pharmaceutical, Inc. - Common Stock Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January 3.23%
64%
Strong
February -1.00%
55%
Weak
March WORST -6.99%
55%
Weak
April -0.69%
36%
Very Weak
May 0.07%
36%
Weak
June 2.14%
55%
Moderate
July -1.72%
36%
Very Weak
August -3.43%
45%
Weak
September 15.89%
55%
Moderate
October -4.48%
36%
Very Weak
November BEST 19.16%
73%
Very Strong
December 3.87%
55%
Moderate

Collegium Pharmaceutical, Inc. - Common Stock 2026 vs Historical Pattern

Current Position
17.51
Historical Avg Position
43.49
Deviation
-25.98
Performance
Significantly Below Average

Collegium Pharmaceutical, Inc. - Common Stock Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for COLL with overlay patterns, custom date ranges, and more.

Create Free Account

Collegium Pharmaceutical, Inc. - Common Stock Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

Collegium Pharmaceutical, Inc. - Common Stock Seasonal Historical Performance

Historical Performance

See historical average returns for COLL across multiple timeframes.

Create Free Account

About Collegium Pharmaceutical, Inc. - Common Stock (COLL) Seasonality

Collegium Pharmaceutical, Inc. - Common Stock (COLL) has been analyzed using 11 years of historical data to identify seasonal patterns. Classified under Stocks, Collegium Pharmaceutical, Inc. - Common Stock shows distinct seasonal tendencies based on historical data.

The strongest month for Collegium Pharmaceutical, Inc. - Common Stock is historically November, with an average return of 19.16% and a win rate of 73%. Conversely, March tends to be the weakest month, averaging -6.99% return.

Looking at the full calendar year, Collegium Pharmaceutical, Inc. - Common Stock has an average annual return of 26.03% with an overall monthly win rate of 50.0%. Out of 12 months, 6 typically show positive average returns.

The seasonal pattern for Collegium Pharmaceutical, Inc. - Common Stock has a consistency score of 54 (Fair), based on 12 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

Collegium Pharmaceutical, Inc. - Common Stock Seasonality FAQ

What is the best month to buy Collegium Pharmaceutical, Inc. - Common Stock (COLL)?

Historically, November has been the best month for Collegium Pharmaceutical, Inc. - Common Stock, with an average return of 19.16% and a win rate of 73%. However, past performance does not guarantee future results.

What is the worst month for Collegium Pharmaceutical, Inc. - Common Stock (COLL)?

Based on historical data, March has been the weakest month for Collegium Pharmaceutical, Inc. - Common Stock, with an average return of -6.99%. This is a historical observation and does not guarantee future results.

How reliable is COLL seasonality data?

The seasonality analysis for Collegium Pharmaceutical, Inc. - Common Stock is based on 11 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use Collegium Pharmaceutical, Inc. - Common Stock seasonality in my trading?

Use Collegium Pharmaceutical, Inc. - Common Stock (COLL) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.